The intranasal salbutamol treatment of lungs in septic rats showed increased of the SGLT1 expression in luminal membrane of lung alveolar cells, reduction of atelectasis, bronchial inflammation and reduction of airway damage, suggesting a potential benefit in ARDS secondary to sepsis. The gene discussed is SLC5A1; the disease is acute respiratory distress syndrome.